GPX4 and COVID-19: In COVID-19 patients, altered iron metabolism, depletion of GSH [281], inactivation of GPX4 [282], and up-regulation of lipid peroxidation biomarkers strongly propose ferroptosis as a plausible mechanism for COVID-19 multi-organ affection, including neuropsychiatric sequelae [283].